LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis

D. Santos Ribeiro (Auderghem, Belgium)

Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session: Pulmonary hypertension in lung diseases
Session type: E-poster session
Number: 288
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Santos Ribeiro (Auderghem, Belgium). LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis. 288

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC - 2017 - Hippo-YAP/TAZ signaling is deranged in IPF
Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Year: 2017

LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



LSC - 2020 - IRF5 regulates airway macrophage metabolic responses to viral challenge
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020


LSC - 2020 - The transcriptome of IPF fibrotic foci identifies the fatty acid metabolism as a critical pathway in fibrogenesis
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020

rHuKGF optimistically attenuates MAPK/ERK mediated cell proliferation pathway in emphysematous lungs
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013

LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017



Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD)
Source: ERS Lung Science Conference 2017
Year: 2017

LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

LSC - 2017 - Targeting glucose metabolism in experimental lung injury and fibrosis
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017

YI02 - Activation of Wnt/beta-catenin signaling promotes lung epithelial repair in emphysema
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012

LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017

TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling
Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019
Year: 2020



LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019



Effect of rHuKGF in vegf dependent cell survival progression in emphysematous condition via akt signalling pathway
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013

LSC - 2020 - Glutathione-S-transferase P promotes Interleukin-1ß-induced inflammation and metabolic reprogramming in mice with allergic airways disease
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020




The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020




The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013


Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015



Insulin resistance exacerbates lung inflammation in obese patients via PI3K/Akt signaling pathway
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019


LSC - 2020 - Caspase-1 activation by cigarette smoke occurs via TLR4/TRIF/caspase-8 axis leading to metabolic alterations in human macrophages
Source: Virtual Congress 2020 – Effects of environmental exposures on lung pathology
Year: 2020